Stroke in Patients with Common Noncancerous Gynecologic Diseases
Neurol Clin Pract 13:e200165, Yamashiro,K.,et al, 2023
Pregnancy, Hormonal Treatments for Infertility, Contraception, and Menopause in Women After Ischemic Stroke
Stroke 48:501-506, Caso, V.,et al, 2017
Variable Presentations of Postpartum Angiopathy
Stroke 43:670-676, Fugate,J.E.,et al, 2012
Reversible Cerebral Vasoconstruction Syndromes
Arch Neurol 68:1005-1012,976, Singhal, A.B.,et al, 2011
Hemorrhagic Manifestations of Reversible Cerebral Vasoconstriction Syndrome: Frequency, Features, and Risk Factors
Stroke 41:2505-2511, 2455, Ducros,A.,et al, 2010
The Clinical and Radiological Spectrum of Reversible Cerebral Vasoconstriction Syndrome. A Prospective Series of 67 Patients
Brain 130:3091-3101, Ducros, A.,et al, 2007
Phenylpropanolamine and the Risk of Hemorrhagic Stroke
NEJM 343:1826-1832,1886, Kernan,W.N.,et al, 2000
Diagnosis and Management of Cerebral Venous Thrombosis:A Scientific Statement From the American Heart Association
Stroke 55:e77-e90, Saposnik,G.,et al, 2024
Cerebrovascular Ischemic Events in Patients with Takayasu Arteritis
Stroke 53:1550-1557, Mirouse, A.,et al, 2022
Reversible Cerebral Vasoconstriciton Syndrome
www.UptoDate.com, June, Singhal, A., 2019
Intracranial and Extracranial Neurovascular Manifestations of Takayasu Arteritis
AJNR 38:766-772, Bond, K.M.,et al, 2017
Hormone Replacement Therapy and Adverse Outcomes in Women with Atrial Fibrillation
Stroke 45:3076-3079, Apostolakis, S.,et al, 2014
Ovarian Hyperstimulation Syndrome and Arterial Stroke
Stroke 46:e6-e8, Thornton, K.G.S. & Couillard, P., 2014
Clinical Features and Diagnosis of Takayasu Arteritis
www.UptoDate.com, July, Hunder, G.G., 2013
Clinical and MRI characteristics of acute migrainous infarction
Neurol 76:1911-1917, Wolf, M.E.,et al, 2011
Malignant Cerebral Venous Thrombosis and Pulmonary Emboli
Neurol 75:e49, Dhillon,A.K.,et al, 2010
A 35-year-old Woman with Uterine Fibroids and Multiple Embolic Strokes
Neurol 64:1479-1480, Srivatsa,A.,et al, 2005
Cerebrovascular manifestations of Takayasu arteritis in Europe
Rheumatol 44:1012-1015, Ringleb, P.A.,et al, 2005
10 Most Commonly Asked Questions About Which Antiplatelet Agent to Prescribe
The Neurologist 9:318-322, Adams,H.P. Jr., 2003
Safety of Tissue Plasminogen Activator for Acute Stroke in Menstruating Women
Stroke 33;2506-2508, Wein,T.H.,et al, 2002
Phenylpropanolamine and Hemorrhagic Stroke
NEJM 344:1094-1095, Ernst,M.E.,et al, 2001
Prospective Study of Aspirin Use and Risk of Stroke in Women
Stroke 30:1764-1771, Iso,H.,et al, 1999
Retinocochleocerebral Vasculopathy
Medicine 77:12-40, Petty,G.W.,et al, 1998
Clinical & Angiographic Predictors of Stroke & Death from Carotid Endarterectomy:Syst Review
BMJ 315:1571-1577, Rothwell,P.M.,et al, 1997
Takayasu's Arteritis
Stroke Syndromes, Eds Bogousslavsky & Caplan, Cambridge Univ Press, Chp 48, p 439-442, Naritomi,H., 1995
Takayasu Arteritis
Ann Int Med 120:919-929, Kerr,G.S.,et al, 1994
A Critical Appraisal of Ticlopidine, A New Antiplat Agent, Effectiveness & Clin Indic for Prophylaxis
Arch Int Med 152:1376-1380, Haynes,R.B.,et al, 1992
Stroke Prevention in Women:role of Aspirin Versus Ticlopidine
Am J Med 91:288-292, Hershey,L.A., 1991